论文部分内容阅读
目的观察蛛网膜下腔出血应用尼莫地平治疗的临床疗效。方法选取我院2013年2月~2014年2月间收治的蛛网膜下腔出血患者33例,对照组给予常规处理,观察组同时给予尼莫地平治疗,比较两组临床疗效。结果经过治疗,观察组总有效率(94.44%)与对照组(80.00%)比较明显较高,并发症少,两组患者临床疗效差异显著,有统计学意义(P<0.05)。结论蛛网膜下腔出血应用尼莫地平治疗疗效确切,并发症少,安全可靠。
Objective To observe the clinical efficacy of nimodipine in the treatment of subarachnoid hemorrhage. Methods Thirty-three patients with subarachnoid hemorrhage who were treated in our hospital from February 2013 to February 2014 were selected. The control group was given routine treatment. The observation group was treated with nimodipine. The clinical efficacy was compared between the two groups. Results After treatment, the total effective rate (94.44%) in the observation group was significantly higher than that in the control group (80.00%), with fewer complications. The clinical efficacy of the two groups was significantly different (P <0.05). Conclusion The application of nimodipine in treatment of subarachnoid hemorrhage has definite curative effect, less complication, safe and reliable.